Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001540502-16-000001
Filing Date
2016-04-19
Accepted
2016-04-19 16:45:24
Documents
1
Effectiveness Date
2016-04-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9731
  Complete submission text file 0001540502-16-000001.txt   10809
Mailing Address 4320 FOREST PARK AVE. SUITE 303 SAINT LOUIS MO 63108
Business Address 4320 FOREST PARK AVE. SUITE 303 SAINT LOUIS MO 63108 314-932-4032
Confluence Life Sciences, Inc. (Filer) CIK: 0001540502 (see all company filings)

EIN.: 272100348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-261658 | Film No.: 161579521